Bill 213: Women's Health Strategy Act

The businesses most likely to feel the effects of this bill are in the health technology, medical research, and health innovation sectors operating in Nova Scotia — think companies developing diagnostic tools, digital health platforms, or conducting clinical research. Healthcare providers, clinics, and health professional training programs across the province may also see shifts in curriculum requirements and care standards as the strategy rolls out. Smaller community health organizations and Indigenous health groups could gain access to new funding streams or partnership opportunities through the investment plan. There's no direct regulatory burden on most businesses, but health-tech firms and research institutions positioned in Nova Scotia stand to benefit from government partnerships and procurement tied to the strategy.